GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotechnology Assets SA (XMAD:BST) » Definitions » Price-to-Operating-Cash-Flow

Biotechnology Assets (XMAD:BST) Price-to-Operating-Cash-Flow : 19.71 (As of Dec. 12, 2024)


View and export this data going back to 2011. Start your Free Trial

What is Biotechnology Assets Price-to-Operating-Cash-Flow?

As of today (2024-12-12), Biotechnology Assets's share price is €0.335. Biotechnology Assets's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was €0.02. Hence, Biotechnology Assets's Price-to-Operating-Cash-Flow Ratio for today is 19.71.

The historical rank and industry rank for Biotechnology Assets's Price-to-Operating-Cash-Flow or its related term are showing as below:

XMAD:BST' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.04   Med: 6.2   Max: 414
Current: 19.46

During the past 13 years, Biotechnology Assets's highest Price-to-Operating-Cash-Flow Ratio was 414.00. The lowest was 2.04. And the median was 6.20.

XMAD:BST's Price-to-Operating-Cash-Flow is ranked better than
63.05% of 295 companies
in the Biotechnology industry
Industry Median: 26.38 vs XMAD:BST: 19.46

Biotechnology Assets's Cash Flow from Operations per share for the six months ended in Jun. 2024 was €0.00. Its Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was €0.02.

During the past 12 months, the average Operating Cash Flow per Share Growth Rate of Biotechnology Assets was 466.70% per year. During the past 3 years, the average Operating Cash Flow per Share Growth Rate was -83.60% per year.

During the past 13 years, Biotechnology Assets's highest 3-Year average Operating Cash Flow per Share Growth Rate was 53.70% per year. The lowest was -197.90% per year. And the median was -83.60% per year.

Biotechnology Assets Price-to-Operating-Cash-Flow Historical Data

The historical data trend for Biotechnology Assets's Price-to-Operating-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotechnology Assets Price-to-Operating-Cash-Flow Chart

Biotechnology Assets Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Operating-Cash-Flow
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 2.47 - - 396.00

Biotechnology Assets Semi-Annual Data
Dec14 Jun15 Dec15 Jun16 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24
Price-to-Operating-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Competitive Comparison of Biotechnology Assets's Price-to-Operating-Cash-Flow

For the Biotechnology subindustry, Biotechnology Assets's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biotechnology Assets's Price-to-Operating-Cash-Flow Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biotechnology Assets's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Biotechnology Assets's Price-to-Operating-Cash-Flow falls into.


Biotechnology Assets Price-to-Operating-Cash-Flow Calculation

Biotechnology Assets's Price-to-Operating-Cash-Flow ratio for today is calculated as

Price-to-Operating-Cash-Flow Ratio=Share Price/Cash Flow from Operations per share (TTM)
=0.335/0.017
=19.71

Biotechnology Assets's Share Price of today is €0.335.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Biotechnology Assets's Cash Flow from Operations per share for the trailing twelve months (TTM) ended in Jun. 2024 was €0.02.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: Cash Flow from Operations per share is calculated as Cash Flow from Operations divided by Shares Outstanding (Diluted Average).

It can also be calculated from the numbers for the whole company:

Price-to-Operating-Cash-Flow Ratio=Market Cap/Cash Flow from Operations

Biotechnology Assets Price-to-Operating-Cash-Flow Related Terms

Thank you for viewing the detailed overview of Biotechnology Assets's Price-to-Operating-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotechnology Assets Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biotechnology Assets SA (XMAD:BST) » Definitions » Price-to-Operating-Cash-Flow
Comparable Companies
XMAD:ORY OCSE:NOVO B VRTX REGN ASX:CSL SGEN XKRX:207940 MRNA HKSE:02269 XBRU:ARGX BNTX BGNE SZSE:300122 ALNY OCSE:GMAB XKRX:068270 BMRN XBRU:UCB RPRX LEGN
Traded in Other Exchanges
N/A
Address
Avenida del Desarrollo Tecnologico, No. 11, Scientific and Technological Park, Jerez de la Frontera, ESP, 11591
Website
https://www.biatgroup.com
Biotechnology Assets SA is a clinical-stage biopharmaceutical company developing and producing biological products for the pharmaceutical and veterinarian sectors. It specializes in the prevention and treatment of niche diseases, such as orphan disease, antigens for new-generation vaccines, feed additives, and probiotics. Adl Bionatur offers a portfolio of non-therapeutic and therapeutic products to tier 1 and tier 2 animal health companies. The company's pipeline products include BNT006, BNT007, BNT010, and others.